# FDA Inspection 1229377 - Hainan Shuangcheng Pharmaceuticals Co Ltd - January 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/hainan-shuangcheng-pharmaceuticals-co-ltd/50fdafb7-e72d-4e1c-b7d6-4d4a75dbbca4
Source feed: FDA_Inspections

> FDA Inspection 1229377 for Hainan Shuangcheng Pharmaceuticals Co Ltd on January 26, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229377
- Company Name: Hainan Shuangcheng Pharmaceuticals Co Ltd
- Inspection Date: 2024-01-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1087910 - 2019-04-24](https://www.keypedia.com/records/fda_inspections/hainan-shuangcheng-pharmaceuticals-co-ltd/b48bfdbe-fce4-4515-99e3-93e981585dfb)
- [FDA Inspection 957459 - 2016-01-28](https://www.keypedia.com/records/fda_inspections/hainan-shuangcheng-pharmaceuticals-co-ltd/a1b84e8c-80d0-414b-b747-1db733f9bd17)
- [FDA Inspection 850842 - 2013-08-22](https://www.keypedia.com/records/fda_inspections/hainan-shuangcheng-pharmaceuticals-co-ltd/ccc06d62-37f1-4d40-8cd7-828aede8b59f)

Company: https://www.keypedia.com/companies/hainan-shuangcheng-pharmaceuticals-co-ltd/920c7235-0cdd-4c0a-884c-43e1f605c1c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c